Alzamend Neuro, Inc. (ALZN)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.83+$0.0100 (+0.55%) on the dayAs of the close; data may be delayed.
ALZN price, last 12 months
Key stats
- Previous close
- $1.82
- Open
- $1.90
- Day range
- $1.76 – $1.90
- 52-week range
- $0.8400 – $2.68
- Volume
- 23.3K
- Avg volume (20 days)
- 116.5K
- Market cap
- $8.8M
Performance
1W−3.2%
1M+9.6%
3M+52.5%
6M+22.0%
YTD+0.6%
1Y−23.1%
vs S&P 500, 1Y−39.9 pts
Technicals and fundamentals
About Alzamend Neuro, Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $8.8M